Biora Therapeutics, Inc.
11
Brendan Linehan Shannon
12/27/2024
04/29/2025
Yes
v
| SEALEDMATRIX, LeadSC, PlnDue, DsclsDue, SealedDoc(s), STANDOrder, CLMSAGNT |
Assigned to: Brendan Linehan Shannon Chapter 11 Voluntary Asset |
|
Debtor Biora Therapeutics, Inc.
10070 Carroll Canyon Road Suite 100 San Diego, CA 92131 SAN DIEGO-CA Tax ID / EIN: 27-3950390 fka Progenity, Inc. |
represented by |
Lucas B. Barrett
McDermott Will & Emery LLP One Vanderbilt Avenue New York, NY 10017 United States (212) 547-5400 Fax : (212) 547-5444 Email: lbarrett@mwe.com Carmen Dingman
McDermott Will & Emery LLP 444 West Lake Street, Suite 4000 Chicago, IL 60606-0029 United States (312) 372-2000 Fax : (312) 984-7700 Email: cdingman@mwe.com Bradley Thomas Giordano
McDermott Will & Emery LLP 444 West Lake Street, Suite 4000 Chicago, IL 60606-0029 (312) 372-2000 Fax : (312) 984-7700 Email: bgiordano@mwe.com David R. Hurst
McDermott Will & Emery LLP The Brandywine Building 1000 N. West Street, Suite 1400 Wilmington, DE 19801 302-485-3930 Fax : 302-351-8711 Email: dhurst@mwe.com Jonathan I. Levine
McDermott Will & Emery LLP One Vanderbilt Avenue New York, NY 10017 (212) 547-5400 Fax : (212) 547-5444 Email: jlevine@mwe.com Andrew A. Mark
McDermott Will & Emery LLP 1000 N. West Street, Suite 1400 Wilmington, DE 19801 (302) 485-3900 Fax : (302) 351-8711 Email: amark@mwe.com |
U.S. Trustee U.S. Trustee
Office of the United States Trustee J. Caleb Boggs Federal Building 844 King Street, Suite 2207 Lockbox 35 Wilmington, DE 19801 (302)-573-6491 |
represented by |
Linda J. Casey
Office of United States Trustee 844 King Street Suite 2207 Wilmington, DE 19801 302-573-6491 Fax : 302-573-6497 Email: Linda.Casey@usdoj.gov |
Claims Agent Kroll Restructuring Administration LLC
www.kroll.com/kra 1 World Trade Center 31st Floor New York, NY 10007 |
represented by |
Benjamin Joseph Steele
Kroll Restructuring Administration LLC (F/K/A Prime Clerk LLC) 850 Third Avenue Suite 412 Brooklyn, NY 11232 212-257-5490 Email: bsteele@primeclerk.com |
Transcriber Reliable Companies
Attn: Gene Matthews 1007 North Orange Street Suite 110 Wilmington, DE 19801 302-654-8080 |
| |
Creditor Committee Official Committee of Unsecured Creditors |
represented by |
Theodore S. Heckel
Pachulski Stang Ziehl & Jones LLP 780 Third Avenue, 34th Floor New York, NY 10017 212-561-7700 Fax : 212-561-7777 Email: theckel@pszjlaw.com Paul J. Labov
Pachulski Stang Ziehl & Jones LLP 780 Third Avenue 34th Floor New York, NY 10017-2024 (212)561-7700 Email: plabov@pszjlaw.com Cia H. Mackle
Pachulski Stang Ziehl & Jones LLP 780 Third Avenue, 34th Floor New York, NY 10017-2024 212-561-7700 Email: cmackle@pszjlaw.com Bradford J. Sandler
Pachulski Stang Ziehl & Jones LLP 919 N. Market Street, 17th Floor Wilmington, DE 19801 302-468-7750 Fax : 302-652-4400 Email: bsandler@pszjlaw.com |
| Date Filed | # | Docket Text |
|---|---|---|
| 04/03/2025 | 216 | Order (I) Authorizing the Private Sale of Certain of the Debtor's Assets Free and Clear of Liens, Claims, Encumbrances, and Other Interests, (II) Approving the Asset Purchase Agreement, and (III) Granting Related Relief. (Related Doc # 199, 214) Order Signed on 4/3/2025. (Attachments: # 1 Exhibit 1) (JMW) (Entered: 04/03/2025) |
| 04/03/2025 | 215 | Affidavit/Declaration of Mailing of Ishrat Khan Regarding Order re Third Omnibus Rejection Motion, Order Scheduling Omnibus Hearing Date, and Equipment Private Sale Motion. Filed by Kroll Restructuring Administration LLC. (related document(s)197, 198, 199) (Steele, Benjamin) (Entered: 04/03/2025) |
| 04/03/2025 | 214 | Certificate of No Objection Regarding Debtor's Motion for Entry of an Order (I) Authorizing the Private Sale of Certain of the Debtor's Assets Free and Clear of Liens, Claims, Encumbrances, and Other Interests, (II) Approving the Asset Purchase Agreement, and (III) Granting Related Relief (related document(s)199) Filed by Biora Therapeutics, Inc.. (Hurst, David) (Entered: 04/03/2025) |
| 03/31/2025 | 213 | Motion to Reject Lease or Executory Contract // Debtor's Fourth Omnibus Motion for Entry of an Order (I) Authorizing the Debtor to Reject Certain Executory Contracts Effective as of the Rejection Dates and (II) Granting Related Relief Filed by Biora Therapeutics, Inc.. Hearing scheduled for 5/7/2025 at 10:00 AM at US Bankruptcy Court, 824 Market St., 6th Fl., Courtroom #1, Wilmington, Delaware. Objections due by 4/14/2025. (Attachments: # 1 Notice # 2 Exhibit A) (Hurst, David) (Entered: 03/31/2025) |
| 03/27/2025 | 212 | Affidavit/Declaration of Mailing of Nelson Crespin Regarding First Monthly Fee Application of McDermott Will & Emery LLP, Counsel to the Debtor and Debtor in Possession, for Allowance of Compensation and Reimbursement of Expenses for the Period from December 27, 2024 through January 31, 2025. Filed by Kroll Restructuring Administration LLC. (related document(s)183) (Malo, David) (Entered: 03/27/2025) |
| 03/26/2025 | 211 | Certificate of No Objection - No Order Required Regarding First Monthly Fee Application of McDermott Will & Emery LLP, Counsel to the Debtor and Debtor in Possession, for Allowance of Compensation and Reimbursement of Expenses for the Period from December 27, 2024 Through January 31, 2025 (related document(s)183) Filed by Biora Therapeutics, Inc.. (Hurst, David) (Entered: 03/26/2025) |
| 03/26/2025 | 210 | Certificate of No Objection - No Order Required Regarding Combined Monthly Fee Application of Kroll Restructuring Administration LLC, Administrative Advisor to the Debtor, for Compensation for Services and Reimbursement of Expenses for the Period from December 27, 2024 through January 31, 2025 (related document(s)165) Filed by Biora Therapeutics, Inc.. (Hurst, David) (Entered: 03/26/2025) |
| 03/26/2025 | 209 | Affidavit/Declaration of Mailing of Nelson Crespin Regarding Chapter 11 Monthly Operating Report for the Month Ending: 01/31/2025 Filed by Biora Therapeutics, Inc.. Filed by Kroll Restructuring Administration LLC. (related document(s)154) (Malo, David) (Entered: 03/26/2025) |
| 03/25/2025 | 208 | Request for Service of Notices. Filed by Oracle America, Inc.. (Magnozzi, Mark) (Entered: 03/25/2025) |
| 03/25/2025 | 207 | Chapter 11 Monthly Operating Report for the Month Ending: 02/28/2025 Filed by Biora Therapeutics, Inc.. (Hurst, David) (Entered: 03/25/2025) |